newsfilter
← Latest News
GlobeNewswire·

Medexus Schedules Webinar to Discuss FDA Complete Response Letter for Treosulfan

TORONTO and CHICAGO, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. ("Medexus" or the "Company") (TSX:MDP) (OTCQX:MEDXF) today announced that it has scheduled a webinar on Thursday, August 5, 2021 at 10:00 a.m. Eastern Time to discuss t